1/17/25 21:16 | 1/17/25 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -3 | 0.5808 | 0 | -6 | -43 | 8 | D | | | | | | | | | | | | | | |
1/15/25 16:15 | 1/13/25 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S.m | -11 | 0.5813 | 0 | -20 | -59 | 14 | D | | | | | | | | | | | | | | |
1/17/24 17:30 | 1/16/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S.m | -16 | 0.6962 | 0 | -24 | -54 | 20 | D | | | | | | | | | | | | | | |
1/12/24 17:00 | 1/11/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S.m | -8 | 0.8465 | 0 | -9 | -54 | 8 | D | | | | | | | | | | | | | | |
1/17/23 21:17 | 1/17/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -8 | 1.86 | 0 | -4 | -38 | 7 | D | | | | | | | | | | | | | | |
1/12/23 21:03 | 1/11/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S.m | -15 | 1.72 | 0 | -9 | -52 | 8 | D | | | | | | | | | | | | | | |
1/4/23 21:02 | 1/4/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -6 | 1.69 | 0 | -4 | -38 | 6 | D | | | | | | | | | | | | | | |
1/18/22 21:04 | 1/18/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -14 | 3.19 | 0 | -4 | -37 | 7 | D | | | | | | | | | | | | | | |
1/13/22 21:02 | 1/11/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S.m | -21 | 3.55 | 0 | -6 | -62 | 4 | D | | | | | | | | | | | | | | |
1/5/22 21:08 | 1/4/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -14 | 4.06 | 0 | -3 | -37 | 6 | D | | | | | | | | | | | | | | |
7/2/21 20:01 | 7/2/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -19 | 4.26 | 0 | -4 | -37 | 7 | D | | | | | | | | | | | | | | |
1/12/21 21:01 | 1/12/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -14 | 6.15 | 0 | -2 | -37 | 4 | D | | | | | | | | | | | | | | |
1/5/21 21:01 | 1/4/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -19 | 5.33 | 0 | -3 | -37 | 6 | D | | | | | | | | | | | | | | |
12/15/20 21:00 | 12/14/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | P | 144 | 0.6948 | 0 | 207 | 266 | 285 | D | | | | | | | | | | | | | | |
1/15/20 20:03 | 1/14/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | S | -12 | 5.13 | 0 | -2 | -40 | 4 | D | | | | | | | | | | | | | | |
1/7/20 20:01 | 1/6/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | MD | O | COO | S | -4 | 1.20 | 0 | -4 | -40 | 6 | D | | | | | | | | | | | | | | |
1/16/19 21:31 | 1/14/19 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | MD | O | COO | S | -12 | 5.37 | 0 | -2 | -38 | 4 | D | | | | | | | | | | | | | | |
12/21/15 21:35 | 12/17/15 | ARDX | Ardelyx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bertrand William C Jr | CA | D | | P | 100 | 20.00 | 3 | 5 | New | 5 | D | | -18 | 19 | -7 | 3 | 0 | 11 | -2 | -6 | -6 | -47 | -61 | -60 | -29 |